(Q59074416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

title

Immunosuppression by micromolecular fibrinogen degradation products in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

1 reference

G. Girmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1250379

5 September 2022

H. Pees

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1250379

5 September 2022

G. Schwarze

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1250379

5 September 2022

P. G. Scheurlen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1250379

5 September 2022

language of work or name

English

0 references

publication date

1 February 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

5 February 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1250379

full work available at URL

5 September 2022

http://www.nature.com/articles/259399a0

1 reference

https://api.crossref.org/works/10.1038/259399A0

http://www.nature.com/articles/259399a0.pdf

9 November 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/259399A0

9 November 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

volume

259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

issue

5542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

page(s)

399-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1250379%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/259399a0

13 September 2019

exact match

0 references

cites work

The pharmacological properties of fibrinogen degradation products

1 reference

On immunoinsufficiency in chronic uremic kidney diseases

21 January 2018

1 reference

Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

21 January 2018

1 reference

7 January 2021

Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer

1 reference

7 January 2021

Clinical experience with determination of fibrinogen degradation products

1 reference

7 January 2021

Plaque formation in agar by single antibody-producing cells

1 reference

7 January 2021

The fibrinolytic enzyme system in malignant lymphomas.

1 reference

7 January 2021

Lymphocyte reactivity in pregnant women and newborn infants

1 reference

7 January 2021

Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function

1 reference

7 January 2021

Immune mechanisms in uremia

1 reference

7 January 2021

Drug-induced immunological tolerance to sheep red blood cells in mice: effective combination therapy with vincristine and cyclophosphamide

1 reference

7 January 2021

Protein measurement with the Folin phenol reagent

https://api.crossref.org/works/10.1038/259399A0

19

1 reference